Epoprostenol up-regulates serum adiponectin level in patients with systemic sclerosis: therapeutic implications.
Anna NiemczykJoanna CzuwaraMichał ZarembaLidia RudnickaPublished in: Archives of dermatological research (2021)
Epoprostenol infusions up-regulate the serum concentration of adiponectin in patients with systemic sclerosis. In our opinion, future studies on treatments in systemic sclerosis should address the issue of their effect on adipokine metabolism.